Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitors

Immune checkpoint inhibitors (ICIs) improve clinical outcomes in patients suffering from different types of cancer. Liver toxicity is one of the immune-related adverse events associated with immunotherapy; although not common, its management is challenging as it is extremely heterogeneous in terms o...

Descripción completa

Detalles Bibliográficos
Autores principales: De Martin, Eleonora, Michot, Jean-Marie, Rosmorduc, Olivier, Guettier, Catherine, Samuel, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648167/
https://www.ncbi.nlm.nih.gov/pubmed/33205034
http://dx.doi.org/10.1016/j.jhepr.2020.100170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648167/
https://www.ncbi.nlm.nih.gov/pubmed/33205034
http://dx.doi.org/10.1016/j.jhepr.2020.100170

Ejemplares similares